Role of positron emission tomography-computed tomography in the management of anal cancer

International Journal of Radiation Oncology Biology Physics

Volumn 84, Issue 1, 2012, Pages 66-72

  Mistrangelo, Massimiliano ^a   Pelosi, Ettore ^b   Bellò, Marilena ^a   Ricardi, Umberto ^a   Milanesi, Enrica ^a   Cassoni, Paola ^a   Baccega, Massimo ^c   Filippini, Claudia ^a   Racca, Patrizia ^a   Lesca, Adriana ^c   Munoz, Fernando H ^a   Fora, Gianluca ^a   Skanjeti, Andrea ^a   Cravero, Francesca ^a   Morino, Mario ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b PET Center IRMET SpA   (Italy)

^c MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANAL CANCER; CHEMORADIATION; COMPUTED TOMOGRAPHY; DATA SETS; DETECTION RATES; DIGITAL RECTAL EXAMINATIONS; HISTOLOGICAL EXAMINATION; INGUINAL LYMPH NODES; PELVIC NODES; POSITRON EMISSION; POST TREATMENT; PRE-TREATMENT; RADIATION FIELD; SENTINEL NODE; THERAPY TREATMENT;

BIOPSY; DISEASES; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY;

COMPUTERIZED TOMOGRAPHY;

ADULT; AGED; ANUS CANCER; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CHEMORADIOTHERAPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIGITAL RECTAL EXAMINATION; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECTUM BIOPSY; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; ANAL CANAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CARCINOMA, TRANSITIONAL CELL; DIGITAL RECTAL EXAMINATION; FALSE POSITIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; INGUINAL CANAL; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROCTOSCOPY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 84865688649     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.10.048     Document Type: Article

References (30)

1. L.A.G. Ries, D. Harkins, and M. Krapcho B.K. Edwards, SEER incidence and US mortality, trends 1992-2002 in SEER Cancer statistics review, 1975-2003 2005 National Cancer Institute Baltimore, MD 1 103
2. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
3. N.D. Nigro, V.K. Vaitkeicus, and C.B. Basil Combined therapy for cancer of the anal canal: a preliminary report Dis Colon Rectum 17 3 1974 354 356
4. J.-P. Gerard, O. Chapet, and F. Samiei Management of inguinal lymph node metastases in patients with carcinoma of the anal canal. Experience in a series of 270 patients treated in Lyon and review of the Literature Cancer 92 2001 77 84
5. H. Bartelink, F. Roelofsen, and F. Eschwege Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups J Clin Oncol 15 5 1997 2040 2049
6. T.G. Trautmann, and J.H. Zuger Positron emission tomography for pre-treatment staging and posttreatment evaluation in cancer of the anal canal Mol Imaging Biol 7 2005 309 313
7. S.E. Cotter, P.W. Grigsby, and B.A. Siegel FDG-PET/CT in the evaluation of anal carcinoma Int J Radiat Oncol Biol Phys 65 2006 720 725
8. C. Anderson, M. Koshy, and C. Staley PET-CT fusion in radiation management of patients with anorectal tumors Int J Radiat Oncol Biol Phys 69 1 2007 155 162
9. B.T. Nguyen, D.L. Joon, and V. Khoo Assessing the impact of FDG-PET in the management of anal cancer Radiother Oncol 87 2008 376 382
10. E. de Winton, A.G. Heriot, and M. Ng The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer Br J Cancer 100 2009 693 700
11. M. Mistrangelo, E. Pelosi, and M. Bellò Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of inguinal node metastases in patients with anal cancer Int J Radiat Oncol Biol Phys 77 1 2010 73 78
12. J.K. Schwarz, B.A. Siegel, and F. Dehdashti Tumor response and survival predicted by post therapy FDG-PET/CT in anal cancer Int J Radiat Oncol Biol Phys 71 1 2008 180 186
13. E. Piperkova, B. Raphael, and M. Altinyay Impact of PET/CT on initial staging, restaging and treatment management of anal cancer: a clinical case with literature review J BUON 11 2006 523 527
14. A. Iagaru, R. Kundu, and H. Jadvar Evaluation by 18 F-FDG-PET of patients with anal squamous cell carcinoma Hell J Nucl Med 12 1 2009 26 29
15. A.H. Engledow, J.R.A. Skipworth, and G. Blackman The role of 18FDG PETCT in the clinical management of anal squamous cell carcinoma Colorectal Dis 13 5 2011 532 537
16. 18F] Fluorodeoxyglucose-positron emission tomography/computed tomography for staging and radiotherapy planning in patients with anal cancer Int J Radiat Oncol Biol Phys 81 2 2011 445 451
17. M. Krengli, M.E. Milia, and L. Turri FDG-PET/CT imaging for staging and target volume delineation in conformal radiotherapy of anal carcinoma Radiat Oncol 5 2010 10
18. P.W. Grigsby FDG-PET/CT: new horizons in anal cancer Gastroenterol Clin Biol 33 5 2009 456 458
19. P.F. Engstrom, J.P. Arnoletti, and A.B. Benson III NCCN clinical practice guidelines in oncology. Anal carcinoma J Natl Compr Canc Netw 8 1 2010 106 120
20. Engstrom PF, Arnoletti JP, Benson AB III, et al. NCCN Clinical practice guidelines in oncology: anal carcinoma. vol 2.2011. 2. National Comprehensive Cancer Network. Available at: http://bit.ly/iH4XWj. Accessed March 30, 2012.
21. M. Mistrangelo, M. Bellò, and A. Mobiglia Feasibility of the sentinel node biopsy in anal cancer Q J Nucl Med Mol Imaging 53 1 2009 3 9
22. American Joint Commission on Cancer Anal canal AJCC cancer staging manual 6th ed. 2002 Springer New York 125 130
23. P.J. Ell PET/CT in oncology: a major technology for cancer Chang Gung Med J 28 2005 274 283
24. A. Schrerree, F. Reboul, and D. Martin CT of malignant anal canal tumors Radiographics 10 3 1990 433 453
25. L. Vercellino, V. de Paredes, and V. Nataf Has FDG PET/CT an impact on the management of patients with anal carcinoma? Med Nucl 34 2010 96 102
26. 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) in the management of anal carcinoma Med Nucl 33 2009 415 424
27. S.K. Mai, G. Welzel, and B. Hermann Can the radiation dose to CT-enlarged but FDG-PET-negative inguinal lymph nodes in anal cancer be reduced? Strahlenther Onkol 185 2009 254 259
28. D.E. Cohn, F. Dehdashti, and R.K. Gibb Prospective evaluation of positron emission tomography for the detection of groin node metastases fom vulvar cancer Gynecol Oncol 85 2002 179 184
29. E. Kidd, F. Dehdashti, and B.A. Siegel Anal cancer maximum F-18 fluorodeoxyglucose uptake on positron emission tomography is correlated with prognosis Radiother Oncol 95 2010 288 291
30. H.D. Suit, and H.S. Gallager Intact tumor cells in irradiated tissue Arch Pathol 78 1964 648 651